戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 601作成日:2026年10月24日

2-Chloropyridine → (R)-tert-butyl 3-(pyridin-2-ylamino)piperidine-1-carboxylate

https://huagongshe.com/ja/reaction/601

反応式

関与物質

役割名称HCID仕込み量
反応物2-ChloropyridineHCID 7977—
反応物tert-butyl (3R)-3-aminopiperidine-1-carboxylateHCID 1501974—
試薬Sodium t-butoxideHCID 23676156—
触媒Binap, (A+-)-HCID 634876—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒TolueneHCID 1140—
生成物(R)-tert-butyl 3-(pyridin-2-ylamino)piperidine-1-carboxylateHCID 7163063993.42%

反応条件

温度110 °C

反応手順

Vial 1) Pd2(dba)3 (0.018 g, 0.02 mmol) and BINAP (0.024 g, 0.04 mmol) were mixed in toluene (1mL) under N2 and stirred at rt for 5min. Vial 2) sodium tert-butoxide (0.999 g, 10.08 mmol), tert-butyl (R)-3-aminopiperidine-1-carboxylate (1.249 g, 6.05 mmol) and 2-chloropyridine (0.477 mL, 5.04 mmol) were mixed in toluene (6mL) under N2. Added the catalyst solution from vial 1. The mixture was heated at 110°C in an oil-bath. LCMS (3h): product, no SM left. The reaction was cooled to rt and the solvent was evaporated. Added EtOAc, washed with water. Purified by column chromatography (using SP4 TM HPFC system, KP-Sil (50g) column, A=heptane, B=EtOAc/2M NH3 in MeOH (9/1), 27mL/fr, (0% B 2CV, 0-30% B 10CV, 30% B 2CV)) to yield tert-butyl (R)-3-(pyridin-2-ylamino)piperidine-1-carboxylate (1.306 g, 93 %) as yellow solid. [M+H]+ 278. 1H NMR (400 MHz, CDCl3) d 1.42 (s, 9H), 1.51 - 1.64 (m, 2H), 1.68 - 1.8 (m, 1H), 1.93 - 2.05 (m, 1H), 2.81 - 3.36 (m, 2H), 3.45 - 4.16 (m, 3H), 4.50 (d, 1H), 6.42 (d, 1H), 6.5 - 6.62 (m, 1H), 7.36 - 7.45 (m, 1H), 8.02 - 8.13 (m, 1H). Expected Number of Hs: 23 Assigned Hs: 23.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-3016ae12f45142f49e43a15eaa293eb1
出典メモ750 AstraZeneca ELN dataset